Sun Pharmaceutical Industries Limited held its 34th Annual General Meeting (AGM) on 31 July 2026. The meeting was successfully concluded on that date.
Following the AGM, the scrutinizer has submitted his report to the company. Based on this scrutinizer's report, all resolutions that were specified in the Notice of the 34th AGM dated 06 July 2026 have been passed by the shareholders with the requisite majority.
The resolutions shall become effective in accordance with the applicable provisions of law. The company has submitted the voting results to the relevant authorities, and the scrutinizer report has been made available on the company's website at www.sunpharma.com.
The disclosure is signed by Anoop Anjanikumar Deshpande, Company Secretary and Compliance Officer (ICSI Membership No.: A23983), on behalf of Sun Pharmaceutical Industries Limited.